AFT Forsyth & Company’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.33M Sell
9,399
-25
-0.3% -$12.6K 2.04% 10
2025
Q4
$5.34M Buy
9,424
+45
+0.5% +$24K 2.3% 10
2025
Q3
$4.19M Buy
9,379
+275
+3% +$132K 2.01% 9
2025
Q2
$4.95M Sell
9,104
-10
-0.1% -$5.23K 2.53% 8
2025
Q1
$4.51M Sell
9,114
-95
-1% -$52.5K 2.43% 9
2024
Q4
$4.81M Sell
9,209
-120
-1% -$62.5K 2.36% 9
2024
Q3
$4.58M Buy
9,329
+80
+0.9% +$37.2K 2.26% 9
2024
Q2
$4.11M Buy
9,249
+400
+5% +$159K 2.02% 10
2024
Q1
$3.53M Sell
8,849
-405
-4% -$153K 2.01% 9
2023
Q4
$3.12M Buy
9,254
+90
+1% +$26.8K 1.96% 11
2023
Q3
$2.68M Buy
9,164
+185
+2% +$57.8K 1.96% 10
2023
Q2
$3.07M Sell
8,979
-240
-3% -$72.6K 2.18% 9
2023
Q1
$2.36M Sell
9,219
-205
-2% -$50.5K 1.82% 9
2022
Q4
$2.5M Sell
9,424
-975
-9% -$238K 2.13% 9
2022
Q3
$1.95M Sell
10,399
-160
-2% -$34.4K 1.74% 11
2022
Q2
$2.12M Sell
10,559
-189
-2% -$44.3K 1.71% 13
2022
Q1
$3.24M Sell
10,748
-1,555
-13% -$454K 2.07% 9
2021
Q4
$4.42M Sell
12,303
-15
-0.1% -$5.16K 2.27% 6
2021
Q3
$4.08M Buy
12,318
+138
+1% +$46.3K 2.19% 8
2021
Q2
$3.73M Buy
12,180
+585
+5% +$164K 1.99% 9
2021
Q1
$2.86M Buy
11,595
+3,333
+40% +$839K 1.71% 11
2020
Q4
$2.25M Buy
8,262
+270
+3% +$67K 1.41% 11
2020
Q3
$1.89M Buy
7,992
+36
+0.5% +$8.08K 1.41% 14
2020
Q2
$1.51M Sell
7,956
-3,855
-33% -$691K 1.27% 17
2020
Q1
$1.95M Buy
11,811
+120
+1% +$22K 1.96% 10
2019
Q4
$2.3M Buy
11,691
+246
+2% +$46.1K 1.76% 11
2019
Q3
$2.06M Buy
11,445
+513
+5% +$88.7K 1.7% 13
2019
Q2
$1.91M Buy
10,932
+1,470
+16% +$252K 1.57% 13
2019
Q1
$1.8M Buy
9,462
+435
+5% +$77.3K 1.56% 13
2018
Q4
$1.44M Buy
9,027
+2,970
+49% +$503K 1.43% 16
2018
Q3
$1.16M Buy
6,057
+120
+2% +$21.3K 0.96% 33
2018
Q2
$947K Buy
5,937
+555
+10% +$84.6K 0.83% 40
2018
Q1
$741K Buy
5,382
+1,710
+47% +$239K 0.69% 49
2017
Q4
$447K Buy
+3,672
New +$460K 0.44% 83

Other funds holding ISRG

AFT Forsyth & Company's ISRG Position: Q1 2026 in Review

AFT Forsyth & Company reduced its Intuitive Surgical (ISRG) stake by 0.27% in Q1 2026, selling an estimated $12.6K and leaving 9,399 shares worth $4.33M. The position accounts for 2.04% of the portfolio, ranked #10.

AFT Forsyth & Company first reported a position in ISRG in Q4 2017 and has held it in 34 quarters since. The position peaked at $5.34M in Q4 2025. 2,304 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.

  • AFT Forsyth & Company held 9,399 shares of Intuitive Surgical worth $4.33M as of Q1 2026.
  • AFT Forsyth & Company sold 25 Intuitive Surgical shares in Q1 2026, an estimated $12.6K.
  • Intuitive Surgical made up 2.04% of AFT Forsyth & Company's portfolio in Q1 2026, its #10 holding.
  • AFT Forsyth & Company first reported a position in Intuitive Surgical in Q4 2017 and has held it in 34 quarters since.
  • AFT Forsyth & Company's Intuitive Surgical position peaked at $5.34M in Q4 2025.
  • 2,304 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.

Based on AFT Forsyth & Company's 13F filing for Q1 2026, filed 14 May 2026.